A slowly progressive form of limb-girdle muscular dystrophy type 2C associated with founder mutation in the SGCG gene in Puerto Rican Hispanics

Limb‐girdle muscular dystrophy type 2C (LGMD2C) is considered one of the severe forms of childhood‐onset muscular dystrophy. The geographical distribution of founder mutations in the SGCG gene has a prominent effect on the prevalence of LGMD2C in certain populations. The aim of this study was to confirm the hypothesis that the c.787G>A (p.E263K) mutation in the SGCG gene is a founder mutation among Puerto Rican Hispanics and to characterize the associated clinical and immunohistochemical phenotype. Genotyping of six polymorphic microsatellite markers internal to (D13S232) and flanking (D13S175, D13S292, D13S787, D13S1243, D13S283) the SGCG gene was performed on four unrelated Puerto Rican patients with LGMD2C. Preserved ambulation to the second decade of life was observed in at least two subjects. Immunostaining of skeletal muscle demonstrated absence of γ‐sarcoglycan in all affected subjects. Two markers, D13S232 and D13S292, were highly informative and confirmed that all four families share the haplotype of the mutant allele. Our findings confirm that the E263K missense mutation in the SGCG gene is a founder mutation in Puerto Rican Hispanics. A slowly progressive disease course with prolonged preservation of ambulation can be seen in association with this mutation, providing evidence for phenotypic variability.

[1]  H. Patwa,et al.  Puerto Rican founder mutation G787A in the SGCG gene: a case report of 2 siblings with LGMD 2C. , 2014, Journal of clinical neuromuscular disease.

[2]  N. Risch,et al.  Ancestry-related assortative mating in Latino populations , 2009, Genome Biology.

[3]  K. Bushby,et al.  Sarcoglycanopathies: Can muscle immunoanalysis predict the genotype? , 2008, Neuromuscular Disorders.

[4]  P. Palange,et al.  From the authors , 2007, European Respiratory Journal.

[5]  A. Pestronk,et al.  Limb-Girdle Muscular Dystrophy in the United States , 2006, Journal of neuropathology and experimental neurology.

[6]  L. Kunkel,et al.  A novel mutation in two families with limb-girdle muscular dystrophy type 2C , 2006, Neurology.

[7]  J. Martínez-Cruzado,et al.  Reconstructing the population history of Puerto Rico by means of mtDNA phylogeographic analysis. , 2005, American journal of physical anthropology.

[8]  L. Kunkel,et al.  Phenotype and sarcoglycan expression in Tunisian LGMD 2C patients sharing the same del521-T mutation , 2003, Neuromuscular Disorders.

[9]  M. Zatz,et al.  The 10 autosomal recessive limb-girdle muscular dystrophies , 2003, Neuromuscular Disorders.

[10]  M. Passos-Bueno,et al.  Genotype-phenotype correlations in 35 Brazilian families with sarcoglycanopathies including the description of three novel mutations , 2003, Journal of medical genetics.

[11]  C. Bönnemann,et al.  Primary γ-sarcoglycanopathy (LGMD 2C): broadening of the mutational spectrum guided by the immunohistochemical profile , 2002, Neuromuscular Disorders.

[12]  C. Lalueza-Fox,et al.  MtDNA from extinct Tainos and the peopling of the Caribbean. , 2001, Annals of human genetics.

[13]  C. Navarro,et al.  Evaluation of heart involvement in gamma-sarcoglycanopathy (LGMD2C). A study of ten patients , 2000, Neuromuscular Disorders.

[14]  A. Toutain,et al.  Homogeneous phenotype of the gypsy limb-girdle MD with the γ-sarcoglycan C283Y mutation , 2000, Neurology.

[15]  J. Sanes,et al.  Membrane Targeting and Stabilization of Sarcospan Is Mediated by the Sarcoglycan Subcomplex , 1999, The Journal of cell biology.

[16]  E. Hoffman,et al.  Heart involvement in muscular dystrophies due to sarcoglycan gene mutations , 1999, Muscle & nerve.

[17]  J. Kaplan,et al.  Severe limb girdle muscular dystrophy in Spanish gypsies: further evidence for a founder mutation in the γ-sarcoglycan gene , 1998, European Journal of Human Genetics.

[18]  A. Essen,et al.  A novel γ-sarcoglycan mutation causing childhood onset, slowly progressive limb girdle muscular dystrophy , 1998, Neuromuscular Disorders.

[19]  E. Hoffman,et al.  Genetic epidemiology of muscular dystrophies resulting from sarcoglycan gene mutations. , 1997, Journal of medical genetics.

[20]  E. Hoffman,et al.  Mutations in the sarcoglycan genes in patients with myopathy. , 1997, The New England journal of medicine.

[21]  J. Beckmann,et al.  A founder mutation in the gamma-sarcoglycan gene of gypsies possibly predating their migration out of India. , 1996, Human molecular genetics.

[22]  L. Kunkel,et al.  Mutations That Disrupt the Carboxyl-Terminus of γ-Sarcoglycan Cause Muscular Dystrophy , 1996 .

[23]  L. Kunkel,et al.  Mild and severe muscular dystrophy caused by a single gamma-sarcoglycan mutation. , 1996, American journal of human genetics.

[24]  L. Kunkel,et al.  Mutations in the Dystrophin-Associated Protein γ-Sarcoglycan in Chromosome 13 Muscular Dystrophy , 1995, Science.

[25]  J. Beckmann,et al.  Severe childhood autosomal recessive muscular dystrophy with the deficiency of the 50 kDa dystrophin-associated glycoprotein maps to chromosome 13q12. , 1993, Human molecular genetics.

[26]  M. Fardeau,et al.  Severe childhood muscular dystrophy affecting both sexes and frequent in tunisia , 1983, Muscle & nerve.

[27]  H. Lochmüller,et al.  Chapter 3 - Sarcoglycanopathies , 2011 .

[28]  K. Mathews,et al.  Limb-girdle muscular dystrophy , 2003, Current neurology and neuroscience reports.

[29]  M. Passos-Bueno,et al.  MildandSevere Muscular Dystrophy Caused bya Single y-Sarcoglycan Mutation , 1996 .

[30]  J. Vance,et al.  Mutations in the dystrophin-associated protein gamma-sarcoglycan in chromosome 13 muscular dystrophy. , 1995, Science.

[31]  founder mutation in , 2022 .